Charles River Laboratories | CRL - Cash And Equivalent

Stock Price
183.70
Daily Change
-17.92 -8.89%
Monthly
-15.00%
Yearly
10.48%
Q1 Forecast
204.00

Charles River Laboratories reported $207.1M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agilent USD 1.79B 254M Sep/2025
Align Technology USD 1B 103.43M Sep/2025
Bio-Rad Laboratories USD 395.8M 26.5M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Cigna USD 6.02B 1.7B Sep/2025
CVS Health USD 9.1B 2.69B Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Elevance Health USD 9.49B 778M Dec/2025
Galapagos EUR 64.46M 43.61M Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
Humana USD 5.39B 1.35B Sep/2025
Illumina USD 1.42B 368M Dec/2025
Incyte USD 2.93B 508.08M Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
Lonza CHF 1.11B 286M Dec/2024
McKesson USD 2.96B 1.05B Dec/2025
Merck EUR 1.17B 161M Jun/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Quest Diagnostics USD 432M 113M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
United Therapeutics USD 1.34B 253M Sep/2025
UnitedHealth USD 28.12B 2.49B Dec/2025
Waters USD 459.12M 91.9M Sep/2025
West Pharmaceutical Services USD 628.5M 118.8M Sep/2025